<DOC>
	<DOCNO>NCT02881177</DOCNO>
	<brief_summary>The purpose pilot study determine tolerability , feasibility , preliminary effectiveness intranasal oxytocin administration prior motivational enhancement group therapy session laboratory-based measure addiction , social connectedness , stress responsivity methamphetamine ( meth ) -using men sex men ( MSM ) . The investigator propose randomize , double-blind , study intranasal oxytocin versus placebo 40 IU prior three Motivational Enhancement Group Therapy ( MEGT ) sessions 28 mixed HIV sero-status MSM initiating treatment amphetamine use disorder .</brief_summary>
	<brief_title>Oxytocin HIV Meth Study</brief_title>
	<detailed_description>The high prevalence amphetamine use disorder ( AUD ) among men sex men ( MSM ) lead significant health disparity , include increase risk HIV sero-conversion . Reducing methamphetamine use mitigate HIV risk . Currently psychopharmacological agent exist treatment AUD ; innovative intervention desperately need . Oxytocin , social neuropeptide , well-studied anti-addiction effect animal model substance dependence . The use intranasal oxytocin variety human substance use disorder early investigation , although one study oxytocin 's effect AUD . In population , oxytocin 's effect know vary depend social context . Psychosocial treatment alone show reduce methamphetamine HIV risk MSM community-based clinic San Francisco , The Stonewall Project . The investigator propose randomize , double-blind pilot study psychopharmacological-psychosocial combination therapy , administration intranasal oxytocin versus placebo prior three Motivational Enhancement Group Therapy ( MEGT ) session , 28 mixed HIV sero-status MSM initiating treatment AUD . The investigator aim ass : 1 ) tolerability , 2 ) feasibility large randomize controlled trial , 3 ) exploratory measure efficacy , include : ) urine level methamphetamine metabolite , b ) methamphetamine craving , c ) engagement MEGT third-party coding videotape group session self-reported measure group connectedness , ) psychophysiological stress response group engagement , e ) sexual risk taking .</detailed_description>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>1 . One documented urine toxicology screen positive meth past month 2 . Considering initiate treatment Methamphetamine Use Disorder initiate treatment within past month 3 . History sexual contact men . 1 . Urine toxicology screen positive heroin past month 2 . Meeting Diagnostic Statistical Manual Mental Disorders , Fifth Edition ( DSMV ) criteria current psychotic disorder , severe neuropsychological disorder , current moderatesevere alcohol use disorder , suicidal homicidal ideation intent within past 90days 3 . Hemodialysis inability produce urine sample 4 . Sensitivity : E 216 , E 218 , chlorbutanol hemihydrate ( preservative use nasal spray ) 5 . Nasal Obstruction discharge 6 . Using Hormone supplementation</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>oxytocin</keyword>
	<keyword>tolerability</keyword>
	<keyword>HIV</keyword>
	<keyword>men sex men ( MSM )</keyword>
	<keyword>addiction</keyword>
</DOC>